Benefits of moderate weight loss in patients with type 2 diabetes.
Weight loss is a primary goal of therapy in overweight patients with type 2 diabetes. This review examines whether positive patient outcomes are observed even after relatively small amounts of weight loss, that is, weight loss being more easily attainable in practice. Clinical studies demonstrate that therapeutic benefit rises with increasing weight loss, but that losses as low as 0.45-4 kg (1-9 lb) have positive effects on metabolic control, cardiovascular risk factors and mortality rates. Even the intention to lose weight, without significant success, can improve outcomes in patients with diabetes, presumably because of the healthy behaviours associated with the attempt. The current data support a continued focus on weight loss, including moderate weight loss, as a key component of good care for overweight patients with type 2 diabetes.
Fujioka
Ken
K
Department of Diabetes and Endocrine, Scripps Clinic, San Diego, CA, USA. fujioka.ken@scrippshealth.org
D001067:Appetite Depressants / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000628:therapy*; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D006801:Humans; D009765:Obesity / Q000150:complications / Q000628:therapy*; D040242:Risk Reduction Behavior; D015431:Weight Loss / Q000502:physiology*
D001067:Appetite Depressants